Ztreonam1g

A Destructive Weapon Towards Nosocomial Pathogens

Most Effective and the First Synthetic Monobactam Antibiotic

DOWNLOAD PRODUCT CARD

Download product card to know more about this medicine.

PRODUCT CARD
401 KB

Any
Queries?

We will get back to you with 1-2 business days. Or just call us now.

Aztreonam 1 ODO mg/ 500 mg vial

Most Effective and the First Synthetic Monobactam Antibiotic

Ztreonam 1g(Aztreonam for injection) contains the active ingredient aztreonam, a monobactam antibiotic. It was originally isolated from Chromobacteriumviolaceum. It is a synthetic bactericidal antibiotic. The monobactams, having a unique monocyclic beta-lactam nucleus, are structurally different from other beta-lactam antibiotics (eg, penicillins, cephalosporins, cephamycins). The sulfonic acid substituent in the 1-position of the ring activates the beta-lactam moiety; an aminothiazolyl oxime side chain in the 3-position and a methyl group in the 4-position confer the specific antibacterial spectrum and beta-lactamase stability.

• Efficient than the Third-Generation Cephalosporins, Newer Penicillin Derivatives and the aminoglycosides
• Appears to Cause Less Antibiotic Resistance in Bacteria Co­lonizing the Intestine
• Effective in Gram-Negative Aerobe Infections
• No Ototoxicity and Nephrotoxicity like Aminoglycosides

PHARMACOLOGY

Single 30-minute intravenous infusions of 500 mg, 1 g, and 2 g doses of Aztreonam in healthy subjects produced aztreonam peak serum levels of 54 mcg/ml, 90 mcg/ml, and 204 mcg/ml, respectively, immediately after administration; at 8 hours, serum levels were 1 mcg/ml, 3 mcg/ml, and 6 mcg/ml, respectively (Figure 1). Single 3-minute intravenous injections of the same doses resulted in serum levels of 58 mcg/ml, 125 mcg/ml, and 242 mcg/ml at 5 minutes following completion of injection.